Scilex (SCLX) Holding Company has voluntarily made an early installment payment in the aggregate amount of $13.2 million under its senior secured promissory note issued to Oramed (ORMP) Pharmaceuticals in September 2023. Subsequent to this early installment payment, the remaining principal balance under the Oramed Note will be payable in one final payment on March 21, 2025, and the Oramed Note will be retired in its entirety.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SCLX:
- Scilex announces closing of $17M registered direct offering
- Scilex Holding Co options imply 17.2% move in share price post-earnings
- Scilex to sell 26.4M shares at 59c in registered direct offering
- Scilex Bio says KDS201 currently enrolling with U.S. patient cohort to be added
- Scilex announces Phase 2 trial for obesity enrolling U.S. patient cohort